603087 甘李药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.64110.0835.6403.346-4.450
总资产报酬率 ROA (%)1.5219.2715.1743.047-4.096
投入资产回报率 ROIC (%)1.63010.0045.5973.318-4.406

边际利润分析
销售毛利率 (%)74.55975.84174.83073.25976.300
营业利润率 (%)24.34429.21120.73812.089-33.223
息税前利润/营业总收入 (%)23.04228.55117.4738.720-39.525
净利润/营业总收入 (%)21.91828.22220.18413.046-25.669

收益指标分析
经营活动净收益/利润总额(%)92.22168.35760.61198.43788.691
价值变动净收益/利润总额(%)5.28829.64634.56014.835-1.187
营业外收支净额/利润总额(%)-0.5283.751-0.183-2.9872.335

偿债能力分析
流动比率 (X)7.9866.7224.7327.9856.967
速动比率 (X)6.3745.4863.4186.8726.169
资产负债率 (%)6.7177.9088.2088.3019.628
带息债务/全部投入资本 (%)-0.897-0.801-0.858-1.134-1.156
股东权益/带息债务 (%)-11,086.478-12,387.179-11,561.713-8,756.858-8,562.875
股东权益/负债合计 (%)1,388.6151,164.5071,118.3691,104.609938.613
利息保障倍数 (X)-19.628-15.873-5.414-2.8897.177

营运能力分析
应收账款周转天数 (天)51.29235.84535.31338.649116.694
存货周转天数 (天)422.809379.066449.330389.502576.622